PAMP
REGN icon

Polar Asset Management Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Polar Asset Management Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-400
Closed -$420K – 772
2024
Q3 		$420K Sell
400
-900
-69% -$1M 0.01% 468
2024
Q2 		$1.37M Sell
1,300
-3,720
-74% -$3.61M 0.03% 365
2024
Q1 		$4.83M Sell
5,020
-4,480
-47% -$4.26M 0.08% 215
2023
Q4 		$8.34M Sell
9,500
-16,400
-63% -$13.5M 0.14% 138
2023
Q3 		$21.3M Buy
25,900
+12,500
+93% +$9.82M 0.47% 52
2023
Q2 		$9.63M Buy
+13,400
New +$10.3M 0.17% 158
2020
Q3 		– Sell
-1,280
Closed -$798K – 690
2020
Q2 		$798K Buy
+1,280
New +$727K 0.01% 328

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return